Meir's team (Meir et al., 2017) modified the PD-L1 antibody to adhere to the surface of AuNPs and effectively improved the concentration of antibody drugs at tumor sites by using the efficient targeted drug release ability of AuNPs. This evidence concerns the gene CD274 and neoplasm.